Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Indian J Surg Oncol ; 13(Suppl 1): 47-53, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36691504

ABSTRACT

This is a survey report regarding the Government/trust hospital facilities of Cancer Management in the State of Gujarat, India. Gujarat is a large state with a population of more than six crores. As per the Ahmedabad Cancer Registry, incidence of cancer among males is 98 per 1 lakh people and cancer incidence among females is 78 per 1 lakh people. There are only two cancer-treating hospitals in the state which are comprehensive cancer-treating facilities that offer multi-modality cancer treatment like surgery, chemotherapy and radiotherapy-The Gujarat Cancer Research Institute and Nathalal Parekh Cancer Hospital. Herein, we describe the origins, current facilities and latest developments at these institutes.

2.
Indian J Surg Oncol ; 12(Suppl 1): 210-220, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33223748

ABSTRACT

The pandemic of COVID-19 across the globe triggered national lockdowns hampering normal working for all the essential services including healthcare. In order to reduce transmission and safety of patients and healthcare workers, the elective surgeries have been differed. The visits to the hospitals for follow-ups and consultations received temporary halt. However, we cannot halt the treatment for cancer patients who may or may not be COVID-19 positives. These are emergencies and should be treated ASAP. Conducting emergency surgeries during pandemic like COVID-19 is challenge for surgeons and the entire hospital infrastructure. The available information about COVID-19 and its propensity of contamination through droplets and aerosol need some modifications for conducting surgeries successfully without contaminating the hospital buildings, protecting healthcare teams and the patient. With these objectives, some modifications in the operating theater including surgical techniques for minimal access, laparoscopy, and robotic surgery are proposed in this review article. This review article also discusses the safety measures to be followed for the suspected or confirmed COVID-19 patient and the guidelines and recommendations for healthcare teams while treating these patients. Although there is little evidence of viral transmission through laparoscopic or open approaches, modifications to surgical practice such as the use of safe smoke evacuation and minimizing energy device used to reduce the risk of exposure to aerosolized particles to healthcare team are proposed in this review article.

3.
Indian J Surg ; 77(Suppl 3): 850-2, 2015 Dec.
Article in English | MEDLINE | ID: mdl-27011469

ABSTRACT

The purpose of this study is to investigate the outcomes of emergency external carotid artery ligation in head and neck cancer patients. It is a retrospective observational study of 11 patients with oral cavity and oropharynx cancers who underwent external carotid ligation as an emergency procedure. Prior tracheostomy was done in all the patients as part of the procedure. Parameters studied were the efficacy and safety of the procedure in the form of control of haemorrhage, any postoperative neurological deficit, morbidity and mortality. The study evaluates the efficacy of the intervention purely as an emergency procedure, and oncological outcomes have not been reported. Analysis was done using simple frequencies and proportions. The oropharynx is the most common site of tumour bleeding in head and neck malignancies. Bleeding following external carotid ligation stopped in all the patients immediately without any postoperative mortality or morbidity. No patient had any neurologic deficits postoperatively. There was one case of rebleeding. Emergency external carotid ligation in tumours of the oral cavity and oropharynx is a life-saving and simple procedure with limited morbidity. Prior tracheostomy is recommended in all the patients.

4.
3 Biotech ; 5(5): 685-696, 2015 Oct.
Article in English | MEDLINE | ID: mdl-28324520

ABSTRACT

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common non-skin cancer in the world. Tobacco chewing is implicated with most of the cases of HNSCC but this type of cancer is increasing in non-tobacco chewers as well. This study was instigated to provide comprehensive variant and gene-level data in HNSCC subjects of the Indian population and fill the gap in the literature on comparative assessment of gene mutations in cancer subjects with a habit of tobacco and those without any habit using targeted amplicon sequencing. We performed targeted Amplicon sequencing of 409 tumor suppressor genes and oncogenes, frequently mutated across many cancer types, including head and neck. DNA from primary tumor tissues and matched blood was analyzed for HNSCC patients with a habit of tobacco and those without any habit. PDE4DIP, SYNE1, and NOTCH1 emerged as the highly mutated genes in HNSCC. A total of 39 candidate causal variants in 22 unique cancer driver genes were identified in non-habitual (WoH) and habitual (WH) subjects. Comparison of genes from both the subjects, showed seven unique cancer driver genes (KIT, ATM, RNF213, GATA2, DST, RET, CYP2C19) in WoH, while WH showed five (IL7R, PKHD1, MLL3, PTPRD, MAPK8) and 10 genes (SETD2, ATR, CDKN2A, NCOA4, TP53, SYNE1, KAT6B, THBS1, PTPRT, and FGFR3) were common to both subjects. In addition to this NOTCH1, NOTCH2, and NOTCH4 gene were found to be mutated only in habitual subjects. These findings strongly support a causal role for tobacco, acting via PI3K and MAPK pathway inhibition and stimulation of various genes leading to oncogenic transformations in case of tobacco chewers. In case of non-tobacco chewers it appears that mutations in the pathway affecting the squamous epithelial lineage and DNA repair genes lead to HNSCC. Somatic mutation in CYP2C19 gene in the non-habitual subjects suggests that this gene may have a tobacco independent role in development and progression of HNSCC. In addition to sharing high mutation rate, NOTCH gene family was found to be mutated only in habitual sample. Further, presence of mutated genes not earlier reported to be involved in HNSCC, suggest that the Indian sub-continent may have different sets of genes, as compared to other parts of the world, involved in the development and progression of HNSCC.

5.
Asian Pac J Cancer Prev ; 15(20): 8549-56, 2014.
Article in English | MEDLINE | ID: mdl-25374166

ABSTRACT

Head and neck squamous cell carcinoma (HNSCC) is one of the world top ten most common cancers with its highest occurrence in the Indian subcontinent and different aggressive and etiological behavioural patterns. The scenario is only getting worst with the 5 year survival rates dropping to 50%, persistent treatment failures and frequent cases of relapse/recurrence. One of the major reasons for these failures is the presence of cancer stem cells (CSCs), a small population of cancer cells that are highly tumourigenic, capable of self-renewal and have the ability to differentiate into cells that constitute the bulk of tumours. Notably, recent evidence suggests that cancer stem cells are especially resistant to conventional therapy and are the "drivers" of local recurrence and metastatic spread. Specific markers for this population have been investigated in HNSCC in the hope of developing a deeper understanding of their role in oral cancer pathogenesis, elucidating novel biomarkers for early diagnosis and newer therapeutic strategies. This review covers the fundamental relevance of almost all the CSC biomarkers established to date with a special emphasis on their impact in the process of oral tumourigenesis and their potential role in improving the diagnosis, prognosis and treatment of OSCC patients.


Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Squamous Cell/pathology , Cell Transformation, Neoplastic/pathology , Head and Neck Neoplasms/pathology , Mouth Neoplasms/pathology , Neoplasm Recurrence, Local/pathology , Neoplastic Stem Cells/pathology , Carcinogenesis/pathology , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/therapy , Female , Head and Neck Neoplasms/mortality , Head and Neck Neoplasms/therapy , Humans , Male , Mouth Neoplasms/mortality , Mouth Neoplasms/therapy , Neoplasm Recurrence, Local/mortality , Risk Assessment , Squamous Cell Carcinoma of Head and Neck , Survival Analysis
6.
J Laparoendosc Adv Surg Tech A ; 22(8): 819-23, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23039705

ABSTRACT

AIM: Postcricoid cancer is an aggressive neoplasm that presents specific therapeutic problems. This study compares laparoscopic stomach mobilization following total pharyngolaryngoesophagectomy (TPLE) with open mobilization following TPLE with respect to postoperative recovery, perioperative morbidity, and mortality. SUBJECTS AND METHODS: This is a retrospective study in a contemporary series of patients with resectable postcricoid cancer from a single institute (Gujarat Cancer & Research Institute, M.P. Shah Cancer Hospital, Ahmedabad, Gujarat, India). Twenty-five consecutive patients who underwent laparoscopic TPLE were compared with 40 patients who underwent open TPLE from January 2006 to December 2010. RESULTS: Laparoscopic and open TPLE procedures were compared with respect to patient demographics, operative information (blood loss, duration), and complications. The mean duration of surgery was 3.5 hours in the laparoscopic group and 5.5 hours in the open group. The respective mean blood loss was 290 mL and 460 mL. The respective mean time to full oral intake was 10 days and 11 days. The respective average duration of hospitalization was 13 days and 17 days. In the laparoscopic group, 3 (12%) and 4 (16%) patients had pneumonic consolidation and wound infection, respectively, compared with 8 (20%) and 8 (20%) patients in the open group. In the laparoscopic group, there were two (8%) perioperative deaths, compared with four (10%) in the open group. CONCLUSIONS: Laparoscopic TPLE is safe with less morbidity and mortality and quicker postoperative recovery compared with open surgery.


Subject(s)
Cricoid Cartilage , Esophagectomy/methods , Laparoscopy/methods , Laryngeal Neoplasms/surgery , Stomach/surgery , Adult , Aged , Blood Loss, Surgical/statistics & numerical data , Deglutition Disorders/surgery , Female , Humans , Laryngeal Neoplasms/pathology , Length of Stay , Male , Middle Aged , Retrospective Studies , Tomography, X-Ray Computed
7.
J Minim Access Surg ; 8(2): 45-9, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22623825

ABSTRACT

BACKGROUND: Diagnostic laparoscopy helps in diagnosing and staging Gastrointestinal (GI) cancers. Routine laparoscopy before laparotomy, especially in cancers that have equivocal operability, helps to avoid unnecessary laparotomies. Present study evaluates utility of laparoscopy in diagnosing and staging GI cancers. MATERIALS AND METHODS: Diagnostic laparoscopy was done in 41 patients with gastrointestinal (GI) cancers who were thought to have equivocal operability. Patients with suspected or known non-metastatic GI cancers, in whom resectability was found doubtful by clinical assessment and pre-operative imaging, were included. Patients with non-GI cancers (lymphoma, gynaecologic cancers, genitourinary cancers, retroperitoneal sarcoma, sarcoma and abdominal metastasis of non-GI cancers) and metastatic cancers which were beyond the scope of curative surgery were excluded from the study. RESULTS: After diagnostic laparoscopy (DL) five patients had benign diagnosis. Out of 36 patients with malignant diagnosis, after DL, 22 patients (61.1%) were inoperable, 11 patients (30.6%) were operable, and three (8.3%) patients were of equivocal operability. Sensitivity, specificity, positive predictive value, and negative predictive value of laparoscopy in detecting operability were 100%, 91.7%, 81.8%, and 100%, respectively. CONCLUSIONS: Laparoscopy helped in a significant number of patients with advanced GI cancers to avoid laparotomy. The morbidity of DL was acceptable.

8.
Indian J Surg Oncol ; 2(2): 141-4, 2011 Jun.
Article in English | MEDLINE | ID: mdl-22693406

ABSTRACT

This is an article reporting the largest phyllodes tumor and the role of radiotherapy in patients of phyllodes tumor of breast, based on Medline search for articles in English language using keywords "role of radiotherapy in phyllodes tumor of breast". 32 years female presented with a lump in right breast since last 4 months. This was the second recurrence of similar lump in last 6 years. Biopsy from the lump proved to be cystosarcoma phyllodes. Radical Mastectomy with level I node sampling and reconstruction with Latissimus Dorsi Myocutaneous flap was done as a curative procedure. The tumor measured exactly to be 50 × 25.2 × 16.4 cm in size and 15 kg in weight. Proliferation markers like Ki- 67 and p53 were in the range of 1-2% and 3-4% respectively. Histopathological diagnosis of the tumor was borderline phyllodes tumor. Patient had an uneventful postoperative course and is presently on three monthly follow up since 1 year.

10.
Asian Pac J Cancer Prev ; 8(2): 229-35, 2007.
Article in English | MEDLINE | ID: mdl-17696737

ABSTRACT

OBJECTIVE: Oral cancer is the leading malignancy in India, with tobacco playing a major role in the etiology. The aim of the present study was to quantify nitrate+nitrite (NO2+NO3) in tobacco products as well as to study tobacco exposure related biomarkers in controls, patients with oral precancers (OPC) and oral cancer patients. MATERIALS & METHODS: Healthy individuals (n=90) were grouped into without habit of tobacco (NHT, n=30) and healthy individuals with habit of tobacco (WHT, n=60). Oral cancer patients with a tobacco habit were classified into abstinence (n=62) and non-abstinence (n=64) groups according to status at the study time. Urinary nicotine and cotinine levels were analyzed by modified high-pressure liquid chromatography (HPLC) using a UV detector. Levels of NO2+NO3 in tobacco and urine, and urinary thioether levels were estimated by spectrophotometry. RESULTS: NO2+NO3 levels in different types of tobacco product ranged between 0.13 to 3.39 mg/g. The Odds Ratio (OR) analysis indicated positive associations of both smoking and chewing habits of tobacco with high risk of development of oral cancer. Urinary nicotine, cotinine and NO2+NO3 levels were significantly elevated in WHT, patients with OPC and oral cancer patients as compared with the NHT group. This was also the case for urinary thioether levels. Levels of urinary nicotine and cotinine were also higher in the non-abstinence group with oral cancers. CONCLUSION: The results confirmed that tobacco chewing and smoking habits are prominent risk factors for development of oral cancer in the western part of India (Gujarat). Urinary nicotine, cotinine, NO2+NO3 and thioether levels can be helpful for screening programs for oral cancer.


Subject(s)
Biomarkers, Tumor/urine , Mouth Neoplasms/urine , Smoking/adverse effects , Adult , Aged , Chromatography, High Pressure Liquid , Cotinine/urine , Humans , Middle Aged , Mouth Neoplasms/epidemiology , Nicotine/urine , Nitrates/urine , Nitrites/urine , Odds Ratio , Reference Values , Smoking/urine , Sulfides/urine , Tobacco, Smokeless/adverse effects
11.
World J Surg Oncol ; 5: 50, 2007 May 12.
Article in English | MEDLINE | ID: mdl-17498311

ABSTRACT

BACKGROUND: Meckel's Diverticulum is the most commonly encountered congenital anomaly of the small intestine, occurring in approximately 2% of the population. Occasionally Meckel's diverticulum harbors neoplasms. CASE PRESENTATION: A 65 year old gentleman, presented with a pelvic mass. On exploratory laparotomy, it turned out to be gastrointestinal stromal tumour (GIST) arising from Meckel's diverticulum. Short history and review of literature are discussed. CONCLUSION: Neoplasms occurring from Meckel's diverticulum, even though rare, should be considered as differential diagnosis of pelvic masses arising from bowel, wherever imaging modalities fail to give a definitive diagnosis.


Subject(s)
Gastrointestinal Stromal Tumors/diagnosis , Ileal Neoplasms/diagnosis , Meckel Diverticulum/diagnosis , Neoplasm Invasiveness/pathology , Aged , Biopsy, Needle , Follow-Up Studies , Gastrointestinal Stromal Tumors/surgery , Humans , Ileal Neoplasms/surgery , Immunohistochemistry , Laparotomy/methods , Male , Meckel Diverticulum/surgery , Neoplasm Staging , Risk Assessment , Tomography, X-Ray Computed , Treatment Outcome , Ultrasonography, Doppler
12.
Am Surg ; 68(2): 121-6, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11842954

ABSTRACT

Primary gastrointestinal (GI) lymphomas constitute about 5.6 per cent of total gut neoplasms. The involvement of large bowel as primary site is all the more rare. We carried out this study to evaluate the prevalence and clinicopathological features of large bowel lymphoma at Gujarat Cancer and Research Institute and to compare our findings with published literature. We carried out a retrospective analysis of the records of histologically diagnosed cases of large bowel lymphoma over a 5 year period. A total of eight cases of large bowel lymphoma were identified compared with 57 cases of primary GI lymphoma of other sites, constituting about 12.3 per cent (eight of 65) of all GI lymphomas. Peak incidence was observed in the second decade of life with a mean age at presentation of 30.6 years (range 4-70 years). A male-to-female ratio of one to two was observed. The most commonly presenting feature was altered bowel habits and diarrhea in more than 50 per cent of the patients. One patient presented with acute intestinal obstruction. Diagnosis was made by colonoscopic biopsies in all but one case. All of the patients were treated with surgery and adjuvant chemotherapy. A 4-year disease-free survival of 66.7 per cent was observed (95% confidence interval 0.05-1.28). There was no significant difference in survival in patients with high-grade versus low-grade tumors (50% vs 66.7%; P = 0.88) and stage of disease (75% vs 50%; P = 0.45) in stage II and III respectively. We conclude that large bowel lymphoma is a curable disease if treated aggressively. We suggest that all patients should be treated by primary surgery and should receive adjuvant chemotherapy.


Subject(s)
Intestinal Neoplasms , Lymphoma, Non-Hodgkin , Adolescent , Adult , Aged , Child , Child, Preschool , Combined Modality Therapy , Female , Humans , Intestinal Neoplasms/diagnosis , Intestinal Neoplasms/epidemiology , Intestinal Neoplasms/therapy , Intestine, Large , Lymphoma, Non-Hodgkin/diagnosis , Lymphoma, Non-Hodgkin/epidemiology , Lymphoma, Non-Hodgkin/therapy , Male , Middle Aged , Retrospective Studies , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...